Strategizing the Development of Alzheimer’s Therapeutics

  • Davis J
  • Couch R
N/ACitations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Alzheimer’s Disease is a complex, progressive condition with symptoms that do not reveal themselves until significant changes to neuronal morphology have already occurred. The delayed manifestation of cognitive decline makes determination of the true etiological origins difficult. As a result, identification of ideal drug targets becomes seemingly impossible. The existing treatments for Alzheimer’s Disease may temporarily suppress the rate of cognitive decline, but do little to slow or halt neuronal decay. While many believe that the current approaches to identifying a cure for the disease are too narrow-minded, focusing heavily on the physical manifestations of the diseased brain such as amyloid plaques and neurofibrillary tangles, this review asserts the status of Alzheimer’s research as rational and multi-faceted.

Cite

CITATION STYLE

APA

Davis, J., & Couch, R. (2014). Strategizing the Development of Alzheimer’s Therapeutics. Advances in Alzheimer’s Disease, 03(03), 107–127. https://doi.org/10.4236/aad.2014.33011

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free